Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis

Shweta Mandrekar1, Qingguang Jiang, C Y Daniel Lee

  • 1Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.

Insights

Microglia clear soluble beta-amyloid (sAbeta) via macropinocytosis, a distinct pathway from phagocytosis. This process aids in maintaining brain Abeta homeostasis and peptide degradation.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease involves beta-amyloid (Abeta) deposition and impaired brain clearance.
  • Microglia clear fibrillar Abeta (fAbeta) via phagocytosis, but soluble Abeta (sAbeta) clearance is unclear.

Purpose of the Study:

  • Investigate microglial mechanisms for clearing soluble Abeta (sAbeta).
  • Determine if sAbeta clearance differs from fAbeta clearance.

Main Methods:

  • In vitro and in vivo studies using fluorescently labeled sAbeta.
  • Analysis of microglial uptake mechanisms (macropinocytosis vs. phagocytosis).
  • Microscopic examination of sAbeta localization and degradation within microglia.

Main Results:

  • Microglia internalize sAbeta via non-saturable macropinocytosis, distinct from phagocytosis.
  • sAbeta uptake depends on actin/tubulin dynamics, not clathrin or cholesterol.
  • Internalized sAbeta traffics to late endolysosomes for degradation.
  • sAbeta and fAbeta are cleared through separate mechanisms and compartments.
  • Degraded sAbeta's fluorescent tag is retained intracellularly.

Conclusions:

  • Microglia constitutively clear sAbeta via macropinocytosis, contributing to Abeta homeostasis.
  • This mechanism is distinct from fAbeta clearance and involves intracellular degradation.
  • Identifies a novel pathway for microglial clearance of soluble amyloid peptides.

Related Concept Videos